Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study

Objective—We asked whether single nucleotide polymorphisms (SNPs) that had been nominally associated with cardiovascular disease in antecedent studies were also associated with cardiovascular disease in a population-based prospective study of 4522 individuals aged 65 or older. Methods and Results—Based on antecedent studies, we prespecified a risk allele and an inheritance model for each of 74 SNPs. We then tested the association of these SNPs with myocardial infarction (MI) in the Cardiovascular Health Study (CHS). The prespecified risk alleles of 8 SNPs were nominally associated (1-sided P<0.05) with increased risk of MI in White CHS participants. The false discovery rate for these 8 was 0.43, suggesting that about 4 of these 8 are likely to be true positives. The 4 of these 8 SNPs that had the strongest evidence for association with cardiovascular disease before testing in CHS (association in 3 antecedent studies) were in KIF6 (CHS HR=1.29; 90%CI 1.1 to 1.52), VAMP8 (HR=1.2; 90%CI 1.02 to 1.41), TAS2R50 (HR=1.13; 90%CI 1 to 1.27), and LPA (HR=1.62; 90%CI 1.09 to 2.42). Conclusions—Although most of the SNPs investigated were not associated with MI in CHS, evidence from this investigation combined with previous studies suggests that 4 of these SNPs are likely associated with MI.

[1]  J. Pankow,et al.  Five common gene variants identify elevated genetic risk for coronary heart disease , 2007, Genetics in Medicine.

[2]  E. Topol,et al.  A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Pankow,et al.  Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. , 2007, American journal of epidemiology.

[4]  M. Sabatine,et al.  Asp92Asn Polymorphism in the Myeloid IgA Fc Receptor Is Associated With Myocardial Infarction in Two Disparate Populations: CARE and WOSCOPS , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[5]  E. Topol,et al.  Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[6]  E. Topol,et al.  Identification of four gene variants associated with myocardial infarction. , 2005, American journal of human genetics.

[7]  M. Olivier A haplotype map of the human genome. , 2003, Nature.

[8]  M. Olivier A haplotype map of the human genome , 2003, Nature.

[9]  G. Fonarow,et al.  Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways , 2004, Circulation.

[10]  V. Duffy Associations between oral sensation, dietary behaviors and risk of cardiovascular disease (CVD) , 2004, Appetite.

[11]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[12]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[13]  A. Yashin,et al.  Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins , 2002, Journal of internal medicine.

[14]  G. Reed,et al.  Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. , 2002, Blood.

[15]  Mario Cleves,et al.  Hardy-Weinberg equilibrium test and allele frequency estimation , 1999 .

[16]  L. Kuller,et al.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.

[17]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[18]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[19]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[20]  K. Berg Lp(a) lipoprotein: an overview. , 1994, Chemistry and physics of lipids.

[21]  L. Fried,et al.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[22]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[23]  M. Frick,et al.  Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease , 1974, Clinical genetics.

[24]  C. Furberg,et al.  Pre-Beta1-Lipoprotein: Relationship to Angiographically Proven Coronary Heart Disease and to Lp(a) Lipoprotein , 1974 .